I am originally from Wilson, New York, a small village about 30 miles north of the city of Buffalo on the south shore of Lake Ontario.

I received my B.S. in nuclear engineering from Texas A&M University in 2014 and my M.S. and Ph.D. in biomedical engineering from Boston University in 2018 and 2020, respectively.

I am a computational biologist and bioinformatics scientist working in the field of translational computational oncology research. I am primarily interested in research questions regarding the multiscale interactions between the many biological, chemical, and mechanical actors in the tumor microenvironment, including tumor cells, immune cells, other non-cancerous cells, and other non-cellular features like the extracellular matrix. None of these actors exist in a vacuum, and thus the interactions between these groups are an important determinant of gross tumor behavior. In particular, I study how the interplay between these actors affects tumor progression and patient treatment response, with a particular focus on tumor-immune interactions. To understand these interactions, I develop computational models and large-scale data analysis workflows aided by techniques from machine learning and artificial intelligence and informed by laboratory experiments, next-generation sequencing data, and medical record information. By combining vast amounts of multimodal data, these tools allow the characterization of complex biological phenomena and furthermore, facilitate a deeper understanding of how these systems respond to various chemical and biological factors in the tumor microenvironment, including therapeutic interventions such as immunotherapeutic drugs. Through the careful interpretation and application of the results of these analyses, predictive models and biomarkers can be developed which facilitate a greater understanding of how tumors respond to microenvironmental changes, why some patients respond better to certain treatments than others, and how to best personalize treatment strategies to increase patient treatment response and promote long-term survival and quality-of-life.

When I’m not doing science, I enjoy sailing, cycling, reading history books, and playing the saxophone.